MEDITATION OASIS OF WEIGHTLESSNESS
Share
1. INDICATIONS AND USE
Clinical meditation OASIS OF WEIGHTLESSNESS is indicated for:
HEMATOLOGY
Adjunctive therapy for bleeding disorders:
- Anemia
- Prothrombin gene mutations
- Antiphospholipid syndrome
- Protein S deficiency
- Protein C deficiency
- Antithrombin deficiency
- Disseminated intravascular coagulation (DIC)
- Hereditary hemophilia
- Thrombocytopenia
- Fibrinogen deficiency conditions
Additional therapy for acquired and hereditary anemias:
- Pernicious anemia
- Iron deficiency anemia
- Autoimmune hemolytic anemia
- Macrocytic anemia
- Normocytic anemia
- Sickle cell anemia
- Fanconi anemia
- Diamond-Blackfan anemia
- Thalassemia
- Other types of anemia
- Hemolytic anemia
- Sideroblastic anemia
- Microcytic anemia
IMMUNOLOGY
Adjunctive therapy for HIV (human immunodeficiency virus)
CARDIOLOGY
Adjunctive therapy for hypertension, or high blood pressure:
- Primary or significantly elevated blood pressure
- Secondary high blood pressure caused by another medical condition or the use of certain medications
NEUROLOGY
Additional therapy for logoneurosis (stuttering):
- Developing stuttering
- Neurogenic stuttering
- Psychogenic stuttering
OPHTHALMOLOGY
Adjunctive therapy for blepharospasm:
- Primary or benign essential blepharospasm
- Secondary
PSYCHIATRY
Complementary therapy for psychosomatic disorders:
- Somatic symptomatic disorder
- Illness-related anxiety disorder
- Conversion disorder (functional neurological symptom disorder)
- Psychological factors associated with another disease
- Factorial disorder projected onto oneself or another
- Other specific somatic symptom and related disorder
Adjunctive therapy for post-traumatic stress disorder (PTSD), secondary trauma, or complex post-traumatic stress disorder (CPTSD)
Adjunctive therapy for fear-related agoraphobia:
- Large, open areas or closed spaces
- Crowds
- Places outside the home
- Public transport
PSYCHOLOGY/COACHING
Complementary therapy aimed at eliminating psychological attitudes that affect freedom of action and thinking
Complementary therapy aimed at reducing the body's negative response to stress
Complementary therapy aimed at reducing physical fatigue and the effects of emotional burnout
Complementary therapy aimed at eliminating patterns of behavior that have a negative impact on relationships with children
Complementary therapy aimed at normalizing relationships with others, in particular relationships with strangers
Complementary therapy aimed at developing skills to stabilize reactions and behavioral patterns in conflict situations
SEXOLOGY/UROLOGY
Adjunctive therapy for sexual dysfunction associated with:
- Violations of desire
- Arousal disorders
- Orgasmic disorders
- Pain disorders
2. EXECUTION TIME
2.1 Recommended
In the morning
During the daytime
In the evening
At night
2.2 Not recommended
Before bedtime (no later than 2 hours before bedtime)
3. FREQUENCY OF USE
3.1 Use in patients aged 18 years and over
The minimum course of therapy is 2 months. It is recommended:
- 1 time per week
- as needed
3.2 Use in the elderly
No adjustment of the frequency of administration is required in these patients.
3.3 Administrative information
You can practice meditation while sitting or lying down in any comfortable position.
4. EFFECTIVENESS AND THERAPEUTIC EFFECT
4.1 Start of action
From 1 hour
4.2 Maximum effect
From 8-10 hours
4.3 Decrease in action
From 20-25 hours
4.4 Therapeutic effect
From 1 month
5. CONTRAINDICATIONS
5.1 Meditation is not recommended for use by patients
Within two to three weeks after surgery
In the first two weeks after delivery
6. WARNINGS AND PRECAUTIONS
6.1 Impact on driving vehicles
Does not affect the ability to drive a car
6.2 Drowsiness/sedation
After practicing meditation, there is no drowsiness or sedation.
7. INTERACTION WITH OTHER PRACTICES AND DRUGS
It is recommended to take a break between performing other meditations for at least 30 minutes.
8. USE IN SPECIFIC GROUPS
8.1 Pregnancy
No adjustment of frequency of use is required during pregnancy.
8.2 Lactation period
No adjustment of the frequency of administration is required during lactation.
8.3 Use in pediatrics
Not recommended for persons under 18 years of age
8.4 Geriatric use
No adjustment of the frequency of administration is required in individuals over 65 years of age.
